Yonghong Zhang

8.0k total citations · 1 hit paper
292 papers, 4.7k citations indexed

About

Yonghong Zhang is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Yonghong Zhang has authored 292 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Epidemiology, 74 papers in Cardiology and Cardiovascular Medicine and 56 papers in Molecular Biology. Recurrent topics in Yonghong Zhang's work include Acute Ischemic Stroke Management (65 papers), Blood Pressure and Hypertension Studies (30 papers) and Cerebrovascular and Carotid Artery Diseases (27 papers). Yonghong Zhang is often cited by papers focused on Acute Ischemic Stroke Management (65 papers), Blood Pressure and Hypertension Studies (30 papers) and Cerebrovascular and Carotid Artery Diseases (27 papers). Yonghong Zhang collaborates with scholars based in China, United States and Taiwan. Yonghong Zhang's co-authors include Li‐Qiang Qin, Jia-Yi Dong, Tan Xu, Chongke Zhong, Aili Wang, Jiang He, Hao Peng, Zhong Ju, Aihua Liao and Jian Tong and has published in prestigious journals such as Circulation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Yonghong Zhang

278 papers receiving 4.6k citations

Hit Papers

Triglyceride-glucose inde... 2023 2026 2024 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yonghong Zhang China 33 1.2k 931 889 814 701 292 4.7k
Carmela Rita Balistreri Italy 35 737 0.6× 1.0k 1.1× 1.3k 1.4× 637 0.8× 927 1.3× 160 4.9k
Ioannis Stefanidis Greece 39 1.3k 1.1× 518 0.6× 1.1k 1.2× 385 0.5× 519 0.7× 285 5.5k
Cheng‐Hsien Lu Taiwan 42 1.8k 1.5× 414 0.4× 1.0k 1.2× 393 0.5× 633 0.9× 324 6.7k
Pekka J. Karhunen Finland 48 1.5k 1.3× 528 0.6× 2.0k 2.3× 1.3k 1.6× 840 1.2× 245 7.9k
Francisco Arnalich Spain 41 1.0k 0.9× 1.6k 1.7× 1.2k 1.3× 273 0.3× 814 1.2× 210 6.2k
Chiara Benedetto Italy 49 895 0.8× 738 0.8× 1.3k 1.5× 349 0.4× 915 1.3× 405 9.2k
Ioannis Papassotiriou Greece 46 804 0.7× 336 0.4× 1.2k 1.3× 496 0.6× 1.3k 1.9× 307 7.5k
Inga Peter United States 42 562 0.5× 517 0.6× 2.2k 2.5× 321 0.4× 620 0.9× 143 5.9k
Wolfgang Lieb Germany 44 1.1k 0.9× 391 0.4× 1.4k 1.6× 1.9k 2.3× 1.2k 1.6× 193 6.3k
Masato Eto Japan 49 1.0k 0.9× 632 0.7× 1.5k 1.7× 1.8k 2.2× 1.7k 2.4× 153 7.2k

Countries citing papers authored by Yonghong Zhang

Since Specialization
Citations

This map shows the geographic impact of Yonghong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghong Zhang more than expected).

Fields of papers citing papers by Yonghong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghong Zhang. The network helps show where Yonghong Zhang may publish in the future.

Co-authorship network of co-authors of Yonghong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghong Zhang. A scholar is included among the top collaborators of Yonghong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghong Zhang. Yonghong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yu, Yiming Jia, Yi Liu, et al.. (2025). High Plasma Polyamine Levels Are Associated With an Increased Risk of Poststroke Cognitive Impairment: A Multicenter Prospective Study From CATIS. Journal of the American Heart Association. 14(2). e037465–e037465. 1 indexed citations
2.
Wang, Aili, Jin Zhang, Bizhong Che, et al.. (2024). Serum Soluble Corin and Long‐Term Clinical Outcomes After Acute Ischemic Stroke. Journal of the American Heart Association. 13(19). e035075–e035075. 1 indexed citations
3.
Shi, Mengyao, Yang Liu, Min Chu, et al.. (2024). Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke. Journal of the American Heart Association. 13(19). e036527–e036527. 6 indexed citations
4.
Chang, Xinyue, Pinni Yang, Yi Liu, et al.. (2024). High-Serum Brain-Derived Neurotrophic Factor Levels Are Associated With Decreased Risk of Poststroke Cognitive Impairment. Stroke. 55(3). 643–650. 5 indexed citations
5.
Sun, Lulu, Qilu Zhang, Mengyao Shi, et al.. (2024). Associations Between Gene Variants of Lipid‐Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke. Journal of the American Heart Association. 13(22). e036544–e036544.
6.
Wang, Yan, Bizhong Che, Yanbo Peng, et al.. (2023). The relationship between neurological function trajectory, assessed by repeated NIHSS measurement, and long-term cardiovascular events, recurrent stroke, and mortality after ischemic stroke. International Journal of Stroke. 18(8). 1005–1014. 8 indexed citations
8.
Zhu, Zhengbao, Daoxia Guo, Kaixin Zhang, et al.. (2022). Osteoprotegerin and Ischemic Stroke Prognosis: A Prospective Multicenter Study and Mendelian Randomization Analysis. Stroke. 54(2). 509–517. 4 indexed citations
9.
Liu, Yang, Pinni Yang, Zhengbao Zhu, et al.. (2022). Blood Pressure Fluctuation During Hospitalization and Clinical Outcomes Within 3 Months After Ischemic Stroke. Hypertension. 79(10). 2336–2345. 8 indexed citations
10.
Zhang, Yonghong, et al.. (2021). Advantages and disadvantages of repairing large-segment bone defect. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 25(3). 426.
11.
Liu, Liping, Yilong Wang, Yilong Wang, et al.. (2021). China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design. Stroke and Vascular Neurology. 6(2). 286–290. 4 indexed citations
12.
Zheng, Xiaowei, Yanbo Peng, Chongke Zhong, et al.. (2021). Systolic Blood Pressure Trajectories After Discharge and Long-Term Clinical Outcomes of Ischemic Stroke. Hypertension. 77(5). 1694–1702. 7 indexed citations
13.
Xu, Tan, Hao Peng, Xiaodong Yuan, et al.. (2020). White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke. Stroke. 51(5). 1608–1612. 15 indexed citations
14.
Zhang, Rui, Daoxia Guo, Aili Wang, et al.. (2019). Endostatin as a novel prognostic biomarker in acute ischemic stroke. Atherosclerosis. 293. 42–48. 18 indexed citations
15.
You, Tao, Zhengbao Zhu, Xiaowei Zheng, et al.. (2019). Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke. Journal of Cellular and Molecular Medicine. 23(4). 2901–2906. 12 indexed citations
16.
Wang, Guangli, Chongke Zhong, Hao Peng, et al.. (2019). Renal Function Affects Prognostic Role of Antiphosphatidylserine Antibodies for Acute Ischemic Stroke Patients. Cerebrovascular Diseases. 48(1-2). 1–8. 4 indexed citations
17.
Zhong, Chongke, Xiaoqing Bu, Tan Xu, et al.. (2017). Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke. Atherosclerosis. 266. 1–7. 23 indexed citations
18.
Liu, Yan, et al.. (2015). Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults. BMJ Open. 5(12). e009085–e009085. 12 indexed citations
19.
Guo, Xiaofan, Zhao Li, Liang Guo, et al.. (2014). An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities. BMC Public Health. 14(1). 1046–1046. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026